HC, I'm not thrilled about seeing the de-listing topic so often but surely it could be in our future. I'm not sure it would have any impact at this point.
The Medtronic prospect is certainly a much more appealing topic. They paid $1.6B for Mazor and their patent portfolio of 50 total global patents. Granted they had a marketed device, but with limited indications. Titan has nearly 50 US patents awarded, plus another 120 international patents and over 80 more US applications already submitted. With Mr. Brar recognized as North America's IP Guru a couple years ago, we should have reasonable confidence that a majority of the apps will be granted. In total, a patent portfolio five times the size of Mazors, for a technology with a broader range of applications/indications than Mazor.
What should that be worth, in light of Mazor's offerings as a comparison?
Message in reply to:
I hear you, I understand your intense frustration but I have to ask was it all planned? Let's think a moment:
10-12 people at Titan doing what 100's most likely should be doing
could they all have been paid off making it look like idiocy to stumble and bumble around like they have been to keep Titan under the radar for a biggun to pounce
Are their marching orders now to award themselves more low priced options and get enough money to complete Milestone 8 - ISO Cert
You think these fools will actually be at the next AGM
Delisting talk is coming and oh by the way, they have 180 days to get things fixed so if we get the warning NOW - it brings us to....wait for it MAY 2020. HHHMMMMMMM Zaring is here, Martha is Medtronic's CEO come April 26th and the AGM is typically in June. Hard to argue that one plausible theory is MDT grabs Titan's SP device as they work on their multiport and have 1 HUGE/dedicated software team to install versions on BOTH robots to launch and smack ISRG in the Nutz come 2021-2022? HHHMMMMMMM
